We are live on ! Find out more
IDYA icon

IDEAYA Biosciences
IDYA

110 hedge funds and large institutions have $820M invested in IDEAYA Biosciences in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 48 increasing their positions, 23 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

238% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 8

109% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 23

21% more funds holding

Funds holding: 91 → 110 (+19)

4.61% more ownership

Funds ownership: 85.59% → 90.2% (+4.6%)

2% less capital invested

Capital invested by funds: $838M → $820M (-$17.6M)

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

Holders
110
Holders Change
+19
Holders Change %
+20.88%
% of All Funds
1.69%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
27
Increased
48
Reduced
23
Closed
8
Calls
$950K
Puts
–
Net Calls
+$950K
Net Calls Change
-$439K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$22.3M
2
State Street
State Street
Massachusetts
+$15.2M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$8.53M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$8.49M
5
WP
Woodline Partners
California
+$8.22M

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$17.3M
2
BlackRock
BlackRock
New York
-$6.55M
3
PIM
Platinum Investment Management
Australia
-$6.29M
4
Invesco
Invesco
Georgia
-$5.33M
5
LGM
Logos Global Management
California
-$5.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
SFM
26
Sphera Funds Management
Israel
$5.57M -$1.37M -58,924 -20%
N
27
Natixis
France
$4.73M +$4.65M +200,000 New
ACM
28
ACT Capital Management
Pennsylvania
$4.1M – – –
UBS Group
29
UBS Group
Switzerland
$2.77M +$1.7M +72,996 +165%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$2.71M +$93.2K +4,012 +4%
Bank of America
31
Bank of America
North Carolina
$2.61M +$2.46M +105,954 +2,299%
IBT
32
International Biotechnology Trust
United Kingdom
$2.58M – – –
Rafferty Asset Management
33
Rafferty Asset Management
New York
$2.52M +$1.75M +75,230 +239%
N
34
Nuveen
North Carolina
$2.48M -$186K -8,012 -6%
Goldman Sachs
35
Goldman Sachs
New York
$2.47M +$1.13M +48,621 +87%
Ensign Peak Advisors
36
Ensign Peak Advisors
Utah
$2.19M +$1.29M +55,496 +150%
Citigroup
37
Citigroup
New York
$2.18M +$1.56M +67,028 +266%
AllianceBernstein
38
AllianceBernstein
Tennessee
$2.11M +$79K +3,400 +4%
Charles Schwab
39
Charles Schwab
California
$1.97M +$6.46K +278 +0.3%
TD Asset Management
40
TD Asset Management
Ontario, Canada
$1.78M +$202K +8,700 +13%
Ameriprise
41
Ameriprise
Minnesota
$1.5M +$1.12M +48,421 +318%
Swiss National Bank
42
Swiss National Bank
Switzerland
$1.4M +$1.38M +59,200 New
Wellington Management Group
43
Wellington Management Group
Massachusetts
$1.3M +$1.28M +54,974 New
JAMONY
44
Jacob Asset Management of New York
California
$1.23M -$62.6K -2,693 -5%
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$1.14M +$606K +26,100 +118%
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$1.12M +$644K +27,710 +140%
BG
47
Bellevue Group
Switzerland
$1.11M +$1.09M +47,000 New
Wells Fargo
48
Wells Fargo
California
$986K +$428K +18,424 +79%
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$981K +$573K +24,688 +147%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$960K +$532K +22,888 +129%
1
2
3 4 5

IDYA Hedge Fund Activity: Q4 2021 in Review

110 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q4 2021, worth a combined $820M — down 2.1% from $838M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new IDYA positions and 8 closed out — a net gain of 19 holders — while 48 added to existing stakes and 23 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $22.3M. The largest seller was RTW Investments, cutting an estimated $17.3M.

  • 110 institutional investors held IDEAYA Biosciences (IDYA) as of Q4 2021, up from 91 in Q3 2021.
  • Funds reported $820M of IDEAYA Biosciences stock for Q4 2021, down 2.1% quarter-over-quarter.
  • 27 funds opened new IDEAYA Biosciences positions in Q4 2021 and 8 closed out, a net change of +19 holders.
  • The largest IDEAYA Biosciences buyer in Q4 2021 was Fidelity Investments, an estimated $22.3M added.
  • The largest IDEAYA Biosciences seller in Q4 2021 was RTW Investments, an estimated $17.3M sold.

Based on aggregated 13F filings for Q4 2021.